Targeting the Gut Microbiota in Coronavirus Disease 2019: Hype or Hope?

Lau, Harry Cheuk-Hay; Ng, Siew C; Yu, Jun

Lau, Harry Cheuk-Hay; Ng, Siew C; Yu, Jun.

Lau HC; Institute of Digestive Disease, Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences, CUHK Shenzhen Research Institute, The Chinese University of Hong Kong, Hong Kong SAR, China.
Ng SC; Institute of Digestive Disease, Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences, CUHK Shenzhen Research Institute, Center for Gut Microbiota Research, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China; Microbiota I-Center (MagIC), Hong Kong SAR, China.
Yu J; Institute of Digestive Disease, Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences, CUHK Shenzhen Research Institute, The Chinese University of Hong Kong, Hong Kong SAR, China.

Gastroenterology ; 162(1): 9-16, 2022 01.

Article in English | MEDLINE | ID: covidwho-1475506

Subject(s)

COVID-19/microbiology; Gastrointestinal Microbiome; SARS-CoV-2; COVID-19/etiology; COVID-19/therapy; Dysbiosis; Fecal Microbiota Transplantation; Gastrointestinal Microbiome/physiology; Humans; Probiotics/therapeutic use; Severity of Illness Index

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Gastrointestinal Microbiome / SARS-CoV-2 / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Gastroenterology Year: 2022 Document Type: Article Affiliation country: J.gastro.2021.09.009

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google